Evidence map›Paper›PMID 26391269›Full record

ReviewDigestive diseases and sciences2016

Helicobacter Pylori Infection: Diagnostic Strategies in Primary Diagnosis and After Therapy.

Nathan S S Atkinson, Barbara Braden

Abstract readReview
PubMed Publisher
In one paragraph

Review in Digestive diseases and sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Clinical validation of a fecal PCR assay forJournal of clinical microbiology · 2026
    Observational
  2. Article
  3. Monoclonal stool antigen test for diagnosingFrontiers in cellular and infection microbiology · 2026
    Article
  4. Phenotypic and genotypic analysis ofFrontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Comparison of chemiluminiscence versus lateral flow assay for the detection of Helicobacter pylori antigen in human fecal samples.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  10. Article
  11. Review
  12. Diagnostic and Therapeutic Management ofHealthcare (Basel, Switzerland) · 2023
    Review
  13. Evolution of Diagnostic Methods forDiagnostics (Basel, Switzerland) · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Current status ofWorld journal of gastroenterology · 2020
    Article
  19. Article
  20. Diagnosis ofJournal of pathogens · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nathan S S AtkinsonTranslational Gastroenterology Unit, Oxford University Hospitals NHS Trust, Headley Way, Oxford, OX3 9DU, UK.
Barbara BradenTranslational Gastroenterology Unit, Oxford University Hospitals NHS Trust, Headley Way, Oxford, OX3 9DU, UK. braden@em.uni-frankfurt.de.ORCID http://orcid.org/0000-0002-8534-6873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate diagnosis of Helicobacter pylori infection pre- and post-treatment is mandatory in the current era of decreasing prevalence and increasing antibiotic resistance. The diagnostic performance of most tests is poorer in clinical situations with low bacterial density which is seen in conditions such as atrophic gastritis or intake of antisecretory and antibiotic medications. Noninvasive tests require less cost and resource but provide excellent accuracy; however, endoscopy with testing of gastric biopsy specimens is indicated where alarming symptoms are present or antibiotic susceptibility testing by culture is desired. Newer modalities such as polymerase chain reaction testing provide additional virulence and antibiotic sensitivity profiling. This article outlines new developments and the key parameters of each test, as careful selection of test modality within the clinical context is required for adequate management of infected symptomatic patients.

Indexed as

Bacteriological TechniquesBreath TestsEndoscopy, GastrointestinalSerologic TestsAntibodies, BacterialAntigens, BacterialBacterial ProteinsBiomarkersBiopsyFecesHelicobacter InfectionsHelicobacter pyloriHumansImmunoglobulin GPredictive Value of TestsTreatment OutcomeAntibodies, BacterialAntigens, BacterialBacterial ProteinsBiomarkersImmunoglobulin GUreaseEndoscopyEradicationHelicobacter pylori infectionHistologyPolymerase chain reactionRapid urease testSerologyStool antigen testUrea breath test

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.